IP Library Granted Patent US 7,693,577
Granted Patent B2
US 7,693,577 · App. 11/656,113 · Granted Apr 6, 2010

Irritable bowel syndrome treatment

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,693,577
App. No.
11/656,113
Granted
Apr 6, 2010
Kind
B2
Abstract

At least one of a plurality of disorders of a patient characterized at least in part by vagal activity innervating at least one of a plurality of organs of the patient is treated by a method that includes positioning a neurostimulator carrier around a body organ of the patient where the organ is innervated by at least a vagal trunk. An electrode is disposed on the carrier and positioned at the vagal trunk. An electrical signal is applied to the electrode to modulate vagal activity by an amount selected to treat the disorder. The signal may be a blocking or a stimulation signal.

Claims (20)

1. A method for treating diarrhea dominant irritable bowel syndrome in a patient comprising:

positioning an electrode on a vagus nerve below a vagal innervation of a heart of the patient, with the nerve innervating at least one of a plurality of alimentary tract organs; and

treating the patient's diarrhea dominant irritable bowel syndrome by applying an electrical signal to the electrode with the signal selected to

a) at least in part, down-regulate neural activity on the vagus nerve,

b) allow partial restoration of nerve activity upon discontinuation of the electrical signal,

c) have a frequency of at least 500 Hz, and

d) reduce pancreatic output via inhibition of pancreo-biliary output;

and wherein the signal is not applied in response to a sensed event.

2. A method according to claim 1 wherein the electrical signal is applied at a frequency selected for the signal to create a neural conduction block on the nerve at a blocking site with the neural conduction block selected to at least partially block nerve impulses on the nerve at the blocking site.

3. A method according to claim 2 wherein application of the neural conduction block is variable by a controller to alter a characteristic of the block.

4. A method according to claim 1 wherein the electrode is placed on the vagus nerve at an esophagus of the patient.

5. A method according to claim 1 wherein the signal has a frequency of about 5,000 Hz.

6. A method according to claim 1 wherein the signal is intermittently applied.

7. A method according to claim 1 wherein the signal is applied to a trunk of the vagus nerve.

8. A method according to claim 1 wherein the signal is applied to a branch of the vagus nerve.

9. A method according to claim 1 wherein the signal is applied to both an anterior vagus nerve and a posterior vagus nerve of the patient.

10. A method according to claim 1 wherein the signal is applied to the vagus nerve at a location near or distal to a diaphragm of the patient.

11. A method according to claim 1 wherein the signal is selected to at least partially block afferent nerve signals.

12. A method according to claim 1 wherein the signal is selected to at least partially block efferent nerve signals.

13. A method according to claim 1 wherein the signal is selected to at least partially block both afferent and efferent nerve signals.

Assignments (2)
SECURITY INTEREST Recorded Jun 19, 2020
From: RESHAPE LIFESCIENCES INC.; RESHAPE MEDICAL LLC
To: ARMISTICE CAPITAL MASTER FUND LTD.
Reel/Frame 052987/0463 →
CHANGE OF NAME Recorded Mar 30, 2018
From: ENTEROMEDICS INC.
To: RESHAPE LIFESCIENCES INC.
Reel/Frame 045949/0495 →